活血降脂颗粒治疗高脂血症的疗效评价

目的 观察“活血降脂颗粒”对原发性高脂血症的调脂作用。方法 280例原发性高脂血症患者随机分成两组，治疗组服用“活血降脂颗粒”，对照组服用“月见草油丸”，两组疗程均为8周。观察其疗效及两组血脂（TC、TG、LDL-C和HDL-C）、血粘度变化等指标。结果 治疗组总有效率（83．57％）优于对照组（43．57％）（p〈0.01）；治疗后两组TC、TG、LDL-C明显降低（p〈0．05），HDL-C明显升高（p〈0．01），且治疗组TG降低明显优于对照组（p〈0．01）；治疗组全血高、低切粘度有一定降低（p〈0．01）。结论 活血降脂颗粒对原发性高脂血症患者（主为TG升高者）有较好的调脂作用，且有一定的降低血粘度的作用。     

复方中药治疗脂肪肝伴高脂血症的疗效

目的：探讨消脂化瘀汤治疗脂肪肝伴高脂血症患者的降脂作用机理及疗效评价。 方法：应用消脂化瘀汤治疗47例脂肪肝伴高脂血症患者（观察组）,并以45例服用西药东宝肝泰片作为对照,于服药前后检测胆固醇（TC）、甘油三酯（TG）、高密度脂蛋白（HDL-C）及全血比黏度。 结果：观察组治疗后TC、TG与治疗前比较均降低( P<0.01),观察组TC、TG降低作用明显优于对照组（P<0.01）; HDL-C治疗后虽有升高,但两组比较差异无显著性(P>0.05);观察组治疗后全血比黏度、血浆比黏度、还原黏度与对照组比较明显降低(P<0.01)。 结论：消脂化瘀汤在降脂的同时,有一定降低全血比黏度的作用,是一种有效的中药降脂合剂。     

蒲参胶囊治疗原发性高脂血症的多中心随机平行对照临床试验

目的进一步评价蒲参胶囊治疗原发性高脂血症的临床疗效.方法多中心随机平行对照临床试验.448例原发性高脂血症患者被随机分为两组:治疗组336例,服用蒲参胶囊;对照组112例,服用脂必妥片;两组疗程均为4周.主要疗效指标为总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)和高度脂蛋白(HDL-C).结果蒲参胶囊能使TC平均降低0.6246mmol/L,TG平均降低1.5343mmol/L,LDL-C平均降低0.5764mmol/L,HDL-C平均升高0.4406mmol/L;其中蒲参胶囊降低TG的疗效优于对照组(P＜0.005).结论蒲参胶囊对原发性高脂血症患者(尤其是TG升高者)有较好的调脂作用.     

降脂汤治疗高脂血症40例疗效观察

目的:探讨降脂汤在治疗高脂血症中的疗效。方法:收集70例门诊及住院高脂血症患者随机分为治疗组和对照组,治疗组给予服用降脂汤,对照组给予服用脂必妥片,8周后观察血清胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)的变化。结果:治疗组中TC、TG、LDL-C明显下降,而HDL-C明显上升,与对照组比较差异有统计学意义(P<0.05)。结论:降脂汤治疗高脂血症疗效显著。     

脂必泰胶囊治疗2型糖尿病伴高脂血症疗效观察

目的观察脂必泰胶囊治疗2型糖尿病伴高脂血症的疗效。方法选取80例2型糖尿病伴高脂血症患者,随机分为对照组和观察组,每组各40例,对照组应用阿伐他汀治疗,观察组应用脂必泰胶囊治疗,治疗时间为6周。观察治疗前后两组患者总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白(LDL-C)以及高密度脂蛋白(HDL-C)的变化及用药期间的不良反应。结果治疗后两组患者TC、TG、LDL-C及HDL-C均明显优于治疗前(P0.05),二者的调脂作用在TC、LDL-C、HDL-C无明显差异(P0.05),观察组TG显著优于对照组(P0.05)。结论脂必泰胶囊治疗2型糖尿病伴高脂血症疗效显著,能够明显降低TG,不良反应低,安全可靠,值得临床推广使用。     

小剂量辛伐他汀联合山楂精降脂片治疗高脂血症的疗效分析

为探讨小剂量辛伐他汀伍用山楂精降脂片治疗高脂血症的临床疗效,分析120例分别接受小剂量辛伐他汀伍用山楂精降脂片(观察组)与常规剂量辛伐他汀(对照组)治疗的高脂血症患者的临床资料.结果 ,观察组及对照组治疗前后血浆中总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)比较差异均有统计学意义(P<0.05),治疗后两组血浆各指标比较差异均有统计学意义(P<0.01);观察组药物不良反应总发生率低于对照组(P<0.05).认为小剂量辛伐他汀伍用山楂精降脂片不仅有全面的降脂调脂作用,而且药物不良反应低,更适合长期应用.     

阿托伐他汀与辛伐他汀治疗原发性高脂血症的临床药理疗效比较

目的 探讨阿托伐他汀与辛伐他汀治疗原发性高脂血症的临床药理疗效.方法 选择广东省湛江市第二人民医院2009年8月～2011年12月原发性高脂血症患者112例,分为观察组(n=56)与对照组(n=56),观察组采用阿托伐他汀治疗,对照组采用辛伐他汀治疗,治疗2个月后比较两组患者的血脂变化及不良反应.结果 两组患者治疗后TC、TG、LDL-C、HDL-C水平与治疗前相比,差异有统计学意义(P<0.05),观察组治疗后TC、TG、LDL-C、HDL-C水平明显优于对照组,差异有统计学意义(P<0.05).观察组疗效明显优于对照组,两组总有效率比较差异有统计学意义(P<0.05),两组不良反应率比较,差异无统计学意义(P>0.05).结论 阿托伐他汀与辛伐他汀均具有较好的降脂作用,但阿托伐他汀在原发性高脂血症治疗中疗效较好,值得临床推广.     

血脂康对高脂血症患者血脂及血管内皮功能的影响

目的:观察血脂康对高脂血症患者血脂水平及血管内皮功能的影响.方法:98例高脂血症患者随机分为观察组49例和对照组49例.观察组口服血脂康胶囊,每天1.2g,连用8周;对照组口服普伐他汀片,每天20mg,连用8周.测定治疗前后两组血甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)及内皮素(ET)、一氧化氮(NO)水平.结果:治疗后,两组TG、TC、LDL-C、ET降低,HDL-C、NO升高,与治疗前比较,差异均有显著性意义(P<0.01或<0.05).观察组与对照组比较,治疗后TG、TC、LDL-C降低及HDL-C升高差异均无显著性意义,但ET降低和NO升高差异有显著性意义(P<0.05).结论:血脂康在改善高脂血症患者血脂异常同时可降低血内皮素、升高血一氧化氮水平,对血管内皮功能有改善作用.血脂康每天1.2g调脂程度与普伐他汀每天20mg相同,但改善血管内皮功能作用强于普伐他汀每天20mg.     

中药配方颗粒降脂合剂治疗高血脂症临床观察

目的:观察中药配方颗粒降脂合剂治疗高血脂症的临床疗效.方法:将符合诊断标准的128例原发性高血脂症患者随机分治疗组和对照组各64例,分别予降中药配方颗粒降脂合剂及辛伐他汀胶囊治疗,疗程8周,观察两组总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)治疗前后的变化及两组疗效.结果:治疗后两组TC、TG、HDL-C、LDL-C较治疗前明显改善,均有统计学差异(P＜0.05);且治疗组总体疗效明显优于对照组(P＜0.05),且未见不良反应.结论:中药配方颗粒降脂合剂治疗高血脂症有较好的疗效,且服用方便,安全性较高.     

补肾调脂汤治疗高脂血症临床观察

目的观察补肾调脂汤治疗肾虚血瘀型高脂血症的临床疗效和安全性及其与c-反应蛋白的关系。方法将符合诊断标准的原发性高脂血症患者60例随机分为治疗组(A)和脂必妥对照组(B),疗程6周,观察2组总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、C反应蛋白(CRP)的变化,及其2组血脂疗效的比较以及TC、TG与CRP的关系。结果6周后TC、TG、HDL-C、LDL-C、CRP A、B组治疗前后及2组间均有统计学差异。2组血脂控制疗效对比P<0.05,CRP与TC、TG存在正相关关系。结论用补肾调脂汤治疗肾虚血瘀型高脂血症有较好的临床效果,且安全性较高。     

Value of D-Dimers in patients with acute aortic dissection

Objective: To evaluatel the value of D-dimers in patients with acute aortic dissection (AAD). Methods: This study consisted of 16 patients with AAD and 27 non-AAD patients. Serum D-dimets were measured by Sta-Liatest D-DI immunoturbidimetric assay. Results: D-dimer level was higher (P ＜ 0.001) in patients with AAD(7.91 ± 5.52 μg/ml) than that in non- AAD group(1.57±1.24 μg/ml). D-dimer was positive (＞0.4 μg/ml) in all patients with AAD and in 10 control group patients (37%). Among patients with acute AAD, D-dimers tended to be higher in Stanford A than in Stanford B (8.67 ± 4.31 μg/ml vs. 3.24±1.27 μg/ml, P ＜0.01). D-dimer values tended to be higher in more extended disease(3.84 ± 1.65 μg/ml, 8.57 ± 3.58 μg/ml and 11.87 ± 5.69 μg/ml in thoracic aorta, thoracic and abdominal aorta, thoracic and abdominal aorta and iliacal arteries, respectively, P ＜ 0.05 for both 8.57 ± 3.58 and 11.87 ± 5.69 vs. 3.84 ± 1.65 ). Including the control group into the analysis, we found a sensitivity of 100%, a negative predictive value of 100%, and a specificity of 66% and a positive predictive value of 64% for D-dimer in diagnosis of AAD in our patients with suspected AAD. Conclusion: D-dimer was elevated in patients with AAD. A negative D-dimer test result could be useful in excluding AAD.     

Research of combined liver-kidney transplantation model in rats

Objective： To set up a simple and reliable rat model of combined liver-kidney transplantation. Methods： SD rats served as both donors and recipients. 4℃ sodium lactate Ringer＇s was infused from portal veins to donated livers,and from abdominal aorta to donated kidneys, respectively. Anastomosis of the portal vein and the inferior vena cava （IVC） inferior to the right kidney between the graft and the recipient was performed by a double cuff method, then the superior hepatic vena cava with suture. A patch of donated renal artery was anastomosed to the recipient abdominal aorta. The urethra and bile duct were reconstructed with a simple inside bracket. Results： Among 65 cases of combined liver-kidney transplantation, the success rate in the late 40 cases was 77.5%. The function of the grafted liver and kidney remained normal. Conclusion： This rat model of combined liver-kidney transplantation can be established in common laboratory conditions with high success rate and meet the needs of renal transplantation experiment.     

BLOOD PRESSURE CHANGE WITH AGE IN SALT-SENSITIVE TEENAGERS

Objective To observe blood pressure change with age in salt-sensitive teenagers whose salt sensitivity were determined by repeated testing.Methods Salt sensitivity was determined through intravenous infusion of normal saline combined with volume-depletion by oral diuretic furosemide in 55 teenagers. After five years, salt sensitivity was re-examined and subject blood pressure was followed up. Blood pressure changes in salt-sensitive teenagers were compared to that of non-salt sensitive teenagers over five years.Results After 5 years, the repetition rate of salt sensitivity determined by intravenous saline loading is 92.7%. In teenagers with salt sensitivity on the baseline, both the systolic blood pressure increments and increment rates were much higher than non-salt sensitive teenagers (12.7±12.1 mmHg vs. 2.8±5.2 mmHg, P＜ 0.01; 12.2%± 12.0% vs. 2.5% ±4.4%, P＜ 0.001,respectively). There was a similar trend for diastolic blood pressure (8.4 ± 6.4 mmHg vs. 3.7 ± 6.4 mmHg, P = 0.052; 13.2% ±10.6 % vs. 6.8%± 10.1%, P = 0.053, respectively).Conclusions Salt sensitivity determined by intravenous saline loading showed good reproducibility. Blood pressure increments with age were much higher in salt-sensitive teenagers than non-salt sensitive teenagers, especially in terms of systolic blood pressure.     

安心颗粒对急诊经皮冠状动脉介入术后生活质量影响的研究

目的：评价使用安心颗粒对急诊经皮冠状动脉介入术（PPCI）术后生活质量的影响.方法：将160例接受PPCI的急性ST段抬高型心肌梗死患者随机分为安心颗粒组（术前顿服安心颗粒8.8g,术后安心颗粒4.4 g/次,每日2次）和对照组（仅接受基础药物治疗）.所有患者均服用阿司匹林、氯吡格雷和阿托伐他汀.分别在入院时、出院前1d、出院后180 d时,应用心肌梗死多维度量表（MIDAS）、中文版SF-36评价量表对患者生活质量评分.并观察术后30 d以内的出血并发症、血小板减少症发生情况.结果：入院时和出院前1d,两组患者的心肌梗死MIDAS、SF-36量表评分比较无差异（P＞0.05）;出院后180 d时,与对照组比较,安心颗粒组MIDAS、SF-36评分明显减低（P＜0.05）;组内与入院时比较,两组出院前1d、出院后180 d时,MIDAS、SF-36评分均降低（P＜0.05）.两组患者在随访期间均无大量出血、少量出血、重度和极重度血小板减少症发生,安心颗粒组有4例、对照组有7例发生不明显出血（P＞0.05）.两组发生轻度血小板减少症的患者数比较无差异（P＞0.05）.结论：PPCI使用安心颗粒,能改善急性ST段抬高型心肌梗死患者的生活质量,且不增加出血风险.     

The comparative studies of the influences of Urapidil and Nicardipine on sino-atrial node function, atrio-ventricular node function and hemodynamics

Objective:To investigate the influences of urapidil and nicardipine on rabbit sinus function,atrio-ventricular node function and hemodynamics.Methods:Thirty-two Angora's rabbits were selected and randomly divided into four groups.U1 group:urapidil 0.25 mg/kg;U2 group:urapidil 0.5 mg/kg;N1 group:nicardipine 10 μg/kg;N2 group:nicardipine 20 μg/kg.All these medicine were administrated within 30 seconds.Measurements were taken before and after the administration of urapidil or nicardipine for the following data:mean blood pressure(MAP),heart rate(HR),sino-atrial conduction time(SACT),maximal sinoatrial recovery time(SNRTmax)corrected sinus node recovery time(CSNRT),index of sinus node recovery time(SNRTI),Wenckebach A-V conduction frequency (WB),and P-R interval.Results:Significant MAP and HR changes were identified in all of the four groups before and after administration of both urapidil and nicardipine.No significant changes could be found in the rest of the parameters.Intergroup analysis showed that SACT and CSNRT of N1 and N2 groups were shorter than those of the U2 group(P＜0.01);the MAP decreased(P＜0.01)and the HR increased drastically(P＜0.01).Conclusions:Neither urapidil(0.25 mg/kg,0.5 mg/kg)nor nicardipine(10μg/kg,20μg/kg)has any significant influence on rabbit sinus function or rabbit atrio-ventricular node function.Nicardipine could be a better choice than urapidil for parafunctional sinus node patients.     

Expression of OPGmRNA and ODFmRNA in the patients of hip fracture due to osteoporosis

Objective：To investigate the gene expression of osteoprotegerin（OPG） and osteoclast differentiation factor（ODF） in the bone tissue of patients with hip fracture due to osteoporosis. Methods：OPGmRNA and ODFmRNA in the bone tissue in 50 cases of osteoporosis sufferers（over 50 years old） with hip fracture（Observer Group） and 30 cases of hip facture sufferers with no osteoporosis（Control group） were analyzed with the Semi-Quantitative RT-PCR method. Results：The mRNA expressed of ODF, OPG were both high in the patients with hip fracture. In the control group, the expression of OPG mRNA was observed, while the expression of ODF mRNA was very slight. Conclusion：Aged patients contained all signals including OPG, ODF that are essential for inducing osteoclastogenesis and promoting bone resorption.     

The clinicopathological and immuohistochemical analysis of solid-pseudopapillary tumor of the pancreas： report of 9 cases

Objective：To investigate the clinical features, pathological characteristics and immunophenotype of solid-pseudopapillary tumor of the pancreas（SPTP）. Methods：Nine surgically treated cases of SPTP were retrospectively reviewed. Hematoxylin and Eosin（HE） staining and immunohistochemical staining were used to analyze all cases, and the general clinical data was collected. Results：Six patients were asymptomatic except for a palpable mass. Two patients complained of vague-epigastric pain. One patient appeared jaundice. The tumor was encapsulated and solid tissues alternately with cystic tissues. Histologically, the histological structure of solid portion was pseudopapillary with a fibrovascular core. Tumor cells were uniform and medium-sized which were arranged in sheets ets or nests or pseudopapillary patterns. Immunohistochemical studies demonstrated that SPTP proved positive in vimentin（9/9 cases）, AAT（9/9 cases）, NSE（9/9 cases）, ACT（7/9 cases）, CK20（2/9 cases）, CgA（1/9 cases）, S-100（3/gcases）, PR（4/gcases）, Syn（3/9 cases） and CD56（5/9cases）, negative in CEA and ER. Conclusion：SPTP is a tumor predominantly occurring in young women frequently without special symptoms. This tumor has various characteristical histological patterns with different immunophenotype.     

Dynamic Changes in Serum Estradiol and Progesterone levels in Patients of Premenstrual Syndrome with Adverse Flow of Liver-qi

Objective:To probe into the influence of changes of ovarian hormones on the pathogenesis of the specific sub-type premenstrual syndrome(PMS)and reveal partial microcosmic mechanisms of adverse flow of liver-qi.Methods:Estradiol(E2)and progesterone(P)levels in serum were determined at different phases of menstrual cycle by radioimmunoassay.Results:In the group of PMS with adverse flow of liver-qi.the secretive peak value Of E2 and P at the follicular phase significantly decreased,and the secretive peak value at the luteal phase did not come into being.Conclusions:Low E2 and P secretive peak at the follicular phase and absence of secretive peak at the luteal phase is one of the microcosmic mechanisms of PMS with adverse flow of liver-qi.One of the pathophysiologic mechanisms of specific sub-type PMS is probably the continuous low level of E2and P.     

Real-time Three-dimensional Echocardiography in Assessment of Left Ventricular and Right Ventricular Volumes

Real-time three-dimensional echocardiography (RT3DE)is a new ultrasound technique that enables dynamic threedimensional visualization and quantification of the heart in real time. Investigation of feasibility and methodology of RT3DE in determining left ventricular (LV) and right ventricular (RV) volumes, RT3DE was performed in 35 normal adults using Philips SONOS 7500 system with a 2-4 MHz matrix array transducer. The 60°×60° "pyramid" volume database was obtained and analyzed on a TomTec echo workstation. Both LV and RV volumes were calculated with four 3DE methods (i.e. apical 2, 4, 8, and 16-plane) through manually tracing ventricular endocardial borders in end diastole and end systole. Stroke volumes were then calculated. LV volume was also measured by 2DE Simpson's rule using GE VIVID 7 ultrasound machine.     

SCREENING FOR A 21-CHROMOSOME ABNORMALITY IN PREIMPLANTED EMBRYOS OF ELDERLY WOMEN

Increasing maternal age is the only etiological factor unequivocally linked to Down's syndrome in humans. The occurrence rate of newborns with Down's syndrome is about 1/220 in women over 35 years old. However, the occurrence rate in embryos fertilized in vitro, of the elder woman is unclear. Using FISH we screened the number of chromosome 21 in preimplanted embryos of 5 elderly women (average age, 38.4 years) to study the feasibility and necessity of screening trisomy 21 in embryos in patients over 35 years old at the in vitro fertilization (IVF) center.